Nordhealth AS - Primary insider notices

Helsinki, Finland, 22 December 2023: Charles MacBain, the CEO and a primary insider of Nordhealth AS (the "Company"), has today sold 1,650,316 class A shares in the Company at a price of NOK 21.34 per share, in two separate transactions to family members who have agreed to vote and dispose of the shares with Charles MacBain.

Following the transactions, Charles MacBain owns 5,773,507 class A shares in the Company. In addition, he holds 24,289,319 class B shares, in total 30,062,826 shares.

Please refer to the attached notifications in accordance with the Market Abuse Regulation article 19 for further details.

For further information, please contact:
Charles MacBain, CEO
charles.macbain@nordhealth.com
+44 75 3903 2200

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries. Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 380 employees working either remotely or from offices (collaboration hubs). Visit the company's website at nordhealth.com (http://www.nordhealth.com.